$3.52
-0.21-5.63%
At close: -
$3.52
0.000.00%
After Hours: 4:30 PM EDT
Comments
Loading...
Mereo BioPharma Group (MREO) Forecast
NewsEarningsMereo BioPharma Group (MREO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMereo BioPharma Group (NASDAQ:MREO) Stock Quotes, Forecast and News Summary
Mereo BioPharma Group Stock (NASDAQ: MREO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mereo BioPharma Group (MREO) stock?
You can purchase shares of Mereo BioPharma Group (NASDAQ:MREO) through any online brokerage.
Who are Mereo BioPharma Group (MREO) competitors?
Other companies in Mereo BioPharma Group’s space includes: Immunome (NASDAQ:IMNM), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT), Sangamo Therapeutics (NASDAQ:SGMO) and Opthea (NASDAQ:OPT).
What is the forecast, or price target, for Mereo BioPharma Group (MREO) stock?
Mereo BioPharma Group has a consensus price target of $7.29.
What is the current price for Mereo BioPharma Group (MREO)?
The stock price for Mereo BioPharma Group (NASDAQ: MREO) is $3.52 last updated December 30, 2024 at 4:30 PM EST.
Does Mereo BioPharma Group (MREO) pay a dividend?
There are no upcoming dividends for Mereo BioPharma Group.
When is Mereo BioPharma Group (NASDAQ:MREO) reporting earnings?
Mereo BioPharma Group’s FY earnings are confirmed for Wednesday, March 26, 2025.
Is Mereo BioPharma Group (MREO) going to split?
There is no upcoming split for Mereo BioPharma Group.
What sector and industry does Mereo BioPharma Group (MREO) operate in?
Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.